Adcentrx Therapeutics
Latest round
- Series A
Last raised
- Dec 2023
Total raised
- $101M
Investors
- 10
About Adcentrx Therapeutics
Based in California, US, and founded in 2021, Adcentrx Therapeutics is a biotechnology company focused on accelerating breakthroughs in antibody drug conjugate (ADC) therapeutic development. Adcentrx Therapeutics was founded by a veteran ADC team with extensive experience in ADC conjugation, target biology and CMC. The founder, Dr. Hui Li, was the CEO of Levena Biopharma, the ADC subsidiary of Sorrento Therapeutics. Dr. Pia Challita-Eid, head of research at Adcentrx, has led teams at Agensys, responsible for novel target and drug discovery. In April 2023, Adcentrx Therapeutics Inc. By combining the targeting precision of biologics and the disease-fighting power of small molecule payloads, Adcentrx Therapeutics strives to develop next-generation targeted therapies for improving patient treatment options.
Who invested in Adcentrx Therapeutics
10 investors across 3 rounds
See all investors in Adcentrx Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Adcentrx Therapeutics
Who invested in Adcentrx Therapeutics?
Adcentrx Therapeutics has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Adcentrx Therapeutics raised?
Adcentrx Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Adcentrx Therapeutics last raise money?
Adcentrx Therapeutics's most recent round on record is a Series A, in Dec 2023.
What does Adcentrx Therapeutics do?
Based in California, US, and founded in 2021, Adcentrx Therapeutics is a biotechnology company focused on accelerating breakthroughs in antibody drug conjugate (ADC) therapeutic development.
Where is Adcentrx Therapeutics headquartered?
Adcentrx Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Adcentrx Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Adcentrx Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Adcentrx Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.